Atlas Trials

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Clinical trial NCT00569309 · COMPLETED

Trial details

NCT number
NCT00569309
Sponsor
Ohio State University Comprehensive Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
LymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer
Start date
2007-12-12
Primary completion
2011-07-29
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.